Facebook
Twitter
LinkedIn
Forward
2023 Vincent T. Andriole ID Board Review Course
To register for this year's pre-meeting workshop, please visit IDWeek.org.
Registration for this course will return by Spring 2025.
This workshop is designed for clinicians, infectious diseases physicians, pharmacists, and advanced practice providers (APPs) preparing for the board exam or seeking a general update and review. Topics that will be addressed include the following: Parasitic Infections, Vaccines, HIV, Rickettsial Diseases, STI’s, Infection Control and Prevention, Transplant Infections and Vector Borne Infections.
Audio/Video content recorded at IDWeekTM 2023 in Boston, MA. Content and presentation format may vary by session.
Moderator(s)
Andrea Zimmer, MD
Assistant Professor
Internal Medicine
University of
Omaha, Nebraska, United States
Disclosure(s): AlloVir: Grant/Research Support (Ongoing)
Stuart Cohen, MD
Medical Director of Hospital Epidemiology; Division Chief, Infectious Diseases
University of California, Davis
Sacramento, CA, United States
Disclosure(s): No financial relationships to disclose
Target Audience
Members-in-training, nonmembers-in-training, residents and medical students.
Learning Objectives
At the conclusion of this session, participants will be able to:
- discuss and apply updated information on diagnosis and treatment of sexually transmitted infections;
- assess and apply current trends in diagnosis and treatment of Tuberculosis and other mycobacteria;
- discuss the diagnosis and treatment of fungal infections;
- discuss common parasitic disease infections including their diagnosis and treatment;
- recognize and apply in diagnostic and therapeutic ways the epidemiologic, tempo, and sign/symptom features of important bacterial infections;
- assess and apply components of effective infection control/prevention programs;
- discuss the most common non-infectious causes of elevated temperature;
- discuss and apply updated information ID therapeutics;
- assess and apply current trends in the diagnosis and treatment of transplant-associated infections;
- assess and apply current trends in HIV care; discuss the diagnosis and treatment of vectorborne diseases.
All relevant financial relationships have been mitigated.
Archana Reddy, MD (she/her/hers)
Assistant Clinical Professor
University of California, Davis Health
Sacramento, CA, United States
Disclosure(s): No financial relationships to disclose
Roy Gulick, MD, MPH
Professor of Medicine Chief, Division of Infectious Diseases
Weill Cornell Medicine
New York, NY, United States
Disclosure(s): No financial relationships to disclose
Philip Budge, MD, PhD
Associate Professor
Washington University St. Louis
St. Louis, MO, United States
Disclosure(s): No financial relationships to disclose
Cody Chastain, MD, FACP, FIDSA (he/him/his)
Assistant Professor of Medicine
Department of Medicine, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN, United States
Disclosure(s): No financial relationships to disclose
Lisa Armitige, MD, PHD
Assistant Medical Director
Heartland National TB Center
San Antonio, TX, United States
Disclosure(s): No financial relationships to disclose
Thomas Patterson, MD
Professor and Chief, Infectious Diseases
University of Texas Health San Antonio
San Antonio, TX, United States
Disclosure(s): Grant Support: Cidara, Gilead, F2G. Consultant: Cidara, F2G, Scynexis, Sfunga
Rachael Lee, MD, MSPH
Associate Professor
Medicine
University of Alabama at Birmingham
Birmingham, AL, United States
Disclosure(s): No financial relationships to disclose
Gerome Escota, MD
Infectious Disease Physician
Park Nicollet Specialty Center
Disclosure(s): No financial relationships to disclose
Catherine O'Neal, MD
Associate Professor of Clinical Medicine, Infectious Diseases
Infectious Diseases
Louisiana State University Health Baton Rouge
Baton Rouge, LA, United States
Disclosure(s): No financial relationships to disclose
Barbara Taylor, MD, MS
Professor
University of Texas Health Science Center San Antonio
San Antonio, TX, United States
Disclosure(s): Gilead Sciences Inc.: Grant/Research Support (Past). NIH funding (NIMH R34, COVID-19 Prevention Network,
RECOVER)
Karen Bloch, MD, MPH
Professor
Vanderbilt University Medical Center
Nashville, TN, United States
Disclosure(s): No financial relationships to disclose
Jessica Lum, MD
Dr
Cleveland Clinic Foundation
Cleveland, OH, United States
Disclosure(s): No financial relationships to disclose
Christopher Ohl, MD
Professor of Medicine
Infectious Diseases
Wake Forest Baptist Health System
Winston Salem, NC, United States
Disclosure(s): No financial relationships to disclose
Accreditation Statement
In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician participation information will be shared with ABIM through ACCME PARS.
Available Credit
- 7.50 ABIM MOC II
- 7.50 AMA PRA Category 1 Credit(s)™